The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease
10.1038/nm.3804 · doi-reference
Redox metabolism: ROS as specific molecular regulators of cell signaling and function
10.1016/j.molcel.2021.08.018 · doi-reference
Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPARα
10.1016/j.bcp.2022.115379 · doi-reference
Pharmacological inhibition of key metabolic pathways attenuates Leishmania spp infection in macrophages
10.1371/journal.pntd.0012763 · doi-reference
The krebs uric acid cycle: A forgotten krebs cycle
10.1016/j.tibs.2018.04.012 · doi-reference
The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD
10.3389/fimmu.2022.1028953 · doi-reference
Lacticaseibacillus plantarum postbiotics prepared by the combined technique of pasteurization and ultrasound: Effective measures to alleviate obesity based on the SCFAs-GPR41/GPR43 signaling pathway
10.1039/d4fo03591g · doi-reference
The Influence of the Protozoan Giardia lamblia on the Modulation of the Immune System and Alterations in Host Glucose and Lipid Metabolism
10.3390/ijms25168627 · doi-reference
Ruminococcus gnavus: Friend or foe for human health
10.1093/femsre/fuad014 · doi-reference
Effects of gabexate mesylate on the gut microbiota and metabolomics in rats with sepsis
10.2147/jir.s392060 · doi-reference
Draft Genome Sequence of Faecalimonas umbilicata JCM 30896T, an Acetate-Producing Bacterium Isolated from Human Feces
10.1128/mra.01091-18 · doi-reference
Chlorogenic acid/linoleic acid-fortified wheat-resistant starch ameliorates high-fat diet-induced gut barrier damage by modulating gut metabolism
10.1021/acs.jafc.4c01595 · doi-reference
Microbiota metabolite butyrate constrains neutrophil functions and ameliorates mucosal inflammation in inflammatory bowel disease
10.1080/19490976.2021.1968257 · doi-reference
Akkermansia muciniphila ameliorates alcoholic liver disease in experimental mice by regulating serum metabolism and improving gut dysbiosis
10.3390/metabo13101057 · doi-reference
Synergistic effects of Ligilactobacillus salivarius Li01 and psyllium husk prevent mice from developing loperamide-induced constipation
10.1039/d4fo04444d · doi-reference
Gut Fungal Microbiome Responses to Natural Cryptosporidium Infection in Horses
10.3389/fmicb.2022.877280 · doi-reference
Cryptosporidium infection induced the dropping of SCFAS and dysbiosis in intestinal microbiome of Tibetan pigs
10.1016/j.micpath.2022.105922 · doi-reference
Intestine microbiota and SCFAs response in naturally Cryptosporidium-infected plateau yaks
10.3389/fcimb.2023.1105126 · doi-reference
The impact of the microbiota-gut-brain axis on Alzheimer’s disease pathophysiology
10.1016/j.phrs.2020.105314 · doi-reference
The abundance and variety of carbohydrate-active enzymes in the human gut microbiota
10.1038/nrmicro3050 · doi-reference
Microbial degradation of complex carbohydrates in the gut
10.4161/gmic.19897 · doi-reference
Bacteroides methylmalonyl-CoA mutase produces propionate that promotes intestinal goblet cell differentiation and homeostasis
10.1016/j.chom.2023.11.005 · doi-reference
Gut Bacteroides species in health and disease
10.1080/19490976.2020.1848158 · doi-reference
The firmicutes/bacteroidetes ratio: A relevant marker of gut dysbiosis in obese patients?
10.3390/nu12051474 · doi-reference
Bacterial O-GlcNAcase genes abundance decreases in ulcerative colitis patients and its administration ameliorates colitis in mice
10.1136/gutjnl-2020-322468 · doi-reference
Brain autoimmunity and intestinal microbiota: 100 trillion game changers
10.1016/j.it.2017.03.008 · doi-reference
Helminths’ therapeutic potential to treat intestinal barrier dysfunction
10.1111/all.15812 · doi-reference
